They may also want to test the liquid part of the bone marrow, called aspirate. There are several tests they can run on ...

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients ...

Beyond oncology, these materials may have applications in non-malignant diseases involving bone degeneration or fractures. "This innovation addresses a significant unmet need in multiple myeloma ...

Multiple Myeloma (MM) is the second most common malignancy of the hematopoietic system, accounting for approximately 10% of all hematological malignancies, and currently, there is no complete cure.

14, 2025 /PRNewswire/ -- Scopio Labs announced today its strategic alliance with Siemens Healthineers has expanded to include the global distribution of Scopio's Full-Field Bone Marrow Aspirate ...

The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

Bone marrow tests to diagnose leukemia include: Bone marrow aspiration: During an aspiration, your healthcare provider will take a sample of the bone marrow using a thin, hollow needle from the ...

Talquetamab combined with teclistamab shows a high response rate in patients with relapsed or refractory multiple myeloma, with 80% responding to the recommended phase 2 regimen.